Elevation Oncology Balance Sheet

Financials in millions NGN. Fiscal year is January - December.

Millions NGN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	4,074	4,311	2,445	2,189	2,872	1,025	Upgrade
Cash & Short-Term Investments	4,074	4,311	2,445	2,189	2,872	1,025	Upgrade
Cash Growth	361.28%	76.34%	11.69%	-23.79%	180.13%	46.05%	Upgrade
Accounts Receivable	963.92	125.48	352.43	44.87	60.74	29.56	Upgrade
Other Receivables	-	29.89	31.63	28.32	39.32	16.43	Upgrade
Receivables	963.92	155.36	384.07	73.2	100.06	45.99	Upgrade
Inventory	3,846	2,856	2,226	1,401	1,024	725.45	Upgrade
Prepaid Expenses	1,443	2.09	92.89	61.96	60.25	4.6	Upgrade
Other Current Assets	528.57	-	54.74	947.03	10.07	6.07	Upgrade
Total Current Assets	10,856	7,324	5,203	4,672	4,066	1,807	Upgrade
Property, Plant & Equipment	14,835	14,021	15,351	10,781	9,407	8,799	Upgrade
Long-Term Deferred Tax Assets	257.07	-	-	-	13.72	762.54	Upgrade
Other Long-Term Assets	0	-	-	-	-	-	Upgrade
Total Assets	25,949	21,345	20,553	15,454	13,487	11,369	Upgrade
Accounts Payable	8,567	4,992	4,034	1,161	1,082	310.94	Upgrade
Accrued Expenses	812.56	1,689	1,047	380.11	1,236	1,122	Upgrade
Short-Term Debt	-	-	1,346	-	-	-	Upgrade
Current Portion of Leases	85.23	191.36	118.08	79.02	71.18	71.18	Upgrade
Current Income Taxes Payable	1,441	1,049	133.87	178.7	80.38	21.66	Upgrade
Current Unearned Revenue	539.8	439.48	308.36	227.68	13.5	-	Upgrade
Other Current Liabilities	615.69	857.18	980.11	900.7	613.9	725.88	Upgrade
Total Current Liabilities	12,061	9,218	7,968	2,927	3,096	2,252	Upgrade
Long-Term Leases	32.08	17.51	127.06	445.08	468.61	486.25	Upgrade
Long-Term Deferred Tax Liabilities	-	14.7	584.87	688.04	-	-	Upgrade
Other Long-Term Liabilities	47.65	39.05	47.64	30.79	-	-	Upgrade
Total Liabilities	12,141	9,289	9,358	4,539	3,928	3,326	Upgrade
Common Stock	4,474	4,474	3,915	3,915	3,915	3,915	Upgrade
Additional Paid-In Capital	-	-	519.1	519.1	519.1	519.1	Upgrade
Retained Earnings	5,632	3,880	3,060	2,779	1,424	-92.47	Upgrade
Comprehensive Income & Other	3,702	3,702	3,702	3,702	3,702	3,702	Upgrade
Shareholders' Equity	13,807	12,056	11,195	10,914	9,559	8,043	Upgrade
Total Liabilities & Equity	25,949	21,345	20,553	15,454	13,487	11,369	Upgrade
Total Debt	117.32	208.87	1,591	524.1	539.79	557.43	Upgrade
Net Cash (Debt)	3,957	4,102	853.4	1,665	2,332	467.8	Upgrade
Net Cash Growth	925.23%	380.65%	-48.73%	-28.62%	398.55%	-33.36%	Upgrade
Net Cash Per Share	0.44	0.46	0.10	0.19	0.26	0.05	Upgrade
Filing Date Shares Outstanding	8,948	8,948	8,948	8,948	8,948	8,948	Upgrade
Total Common Shares Outstanding	8,948	8,948	8,948	8,948	8,948	8,948	Upgrade
Working Capital	-1,205	-1,894	-2,766	1,745	969.97	-444.32	Upgrade
Book Value Per Share	1.54	1.35	1.25	1.22	1.07	0.90	Upgrade
Tangible Book Value	13,807	12,056	11,195	10,914	9,559	8,043	Upgrade
Tangible Book Value Per Share	1.54	1.35	1.25	1.22	1.07	0.90	Upgrade
Land	-	954.1	954.1	954.1	954.1	1,223	Upgrade
Buildings	-	3,332	3,187	2,960	2,697	2,609	Upgrade
Machinery	-	10,560	10,386	8,197	7,595	7,002	Upgrade
Construction In Progress	-	1,553	1,788	787.28	768.22	525.45	Upgrade

Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.